TD Asset Management »

Aeglea Biotherapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.5M 65k 23.28
2024-09-30 $1.5M 53k 28.49
2024-06-30 $827k 35k 23.51
2024-03-31 $2.3M 61k 37.93